LABCORP HOLDINGS INC

LHNYSE

🏆 #391 by market capEarnings Oct 26US Equity

$322.42▲ $1.13 (+0.35%)

🌙 After hours$322.42▲ 0.00%Regular close · extended-hours price shown

1h—

24h▲ 0.3%

7d—

14d—

30d—

1y—

🏦Market Cap

$26.44B

Mid Cap

📈Revenue Growth (YoY)

+7.3%

Slowing

📊Gross Margin

27.9%

Moderate

💵FCF Margin

8.1%

Moderate

⚖️P/S Ratio

1.8x

Cheap

Otter Score

Fair

No chart data available for LH.

Trading Snapshot

Day Range: $321.25 – $327.67
52-Week Range: $244.52 – $323.97
Volume: $2.69B
Avg Volume: $2.55B
Shares Outstanding: 82.0M
Next Earnings: Oct 13, 2026

Fundamentals Snapshot

Annual Revenue: $13.95B
Last Q Revenue: $3.73B
P/E Ratio: 26.5
P/S Ratio: 1.8x
EPS (TTM): $12.27
Dividend Yield: 0.89%

Why Investors Own LH

✓High-growth profile — revenue up +53.9% YoY with expanding US Equity exposure.
✓Healthy economics — 57% gross margin and 17% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$13.95B▲ +60.0% YoY

Gross Margin (TTM)

57.2%▼ −0.2% YoY

Operating Income (TTM)

$2.78B▲ +60.0% YoY

Free Cash Flow (TTM)

$2.33B▲ +60.0% YoY

About LABCORP HOLDINGS INC

Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.

🦦